7th Norwegian Life Science Investor Partnering Day

Life science is entering a new phase. Capital is shifting, investor expectations are evolving, and companies must demonstrate not only strong science, but scalable and globally relevant business models. From strategic pharma partnerships to venture capital recalibrating its playbook, the investment landscape is being reset.

For small-market innovators, this raises critical questions: How do you attract international capital? What defines an investable company in today’s market? And how can Nordic strengths in sustainability, digitalisation, advanced therapeutics and AI translate into global impact?

Norway and the Nordics are uniquely positioned to contribute to the next generation of solutions for human and planetary health. But realising this potential requires alignment between founders, investors, and strategic partners.

Hear Nordic and international investors and thought leaders reflect around the Norwegian and Nordic investment landscape, and meet investors and life science companies for 1:1 partnering.

How do investors look at the challenges and opportunities that come with them?

Learn how Norwegian life science is well positioned to contribute to the next generation of solutions to human and planetary health, and how the Nordics is well positioned for a sustainable and digital life science industry.

Last year’s conference brought ca. 140 participants and nearly 100 1:1 meetings between investors and companies.

NOTE: As a member of Norway Health Tech, you receive a discounted rate on the conference and partnering ticket. Please select the ticket option “Member of conference supporter.”

The updated programme can be found on the conference website.